Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma ; volume:33 ; number:5 ; day:15 ; month:3 ; year:2023 ; pages:3647-3659 ; date:5.2023
European radiology ; 33, Heft 5 (15.3.2023), 3647-3659, 5.2023
- Urheber
-
Moore, Jonathan L.
Subesinghe, Manil
Santaolalla, Aida
Green, Michael
Deere, Harriet
Van Hemelrijck, Mieke
Lagergren, Jesper
Chicklore, Sugama
Maisey, Nick
Gossage, James A.
Kelly, Mark
Baker, Cara R.
Davies, Andrew R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00330-023-09482-7
- URN
-
urn:nbn:de:101:1-2023090121050978568135
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moore, Jonathan L.
- Subesinghe, Manil
- Santaolalla, Aida
- Green, Michael
- Deere, Harriet
- Van Hemelrijck, Mieke
- Lagergren, Jesper
- Chicklore, Sugama
- Maisey, Nick
- Gossage, James A.
- Kelly, Mark
- Baker, Cara R.
- Davies, Andrew R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prediction of pathological response to neo‐adjuvant chemoradiotherapy for oesophageal cancer using vibrational spectroscopy
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT
Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
Predicting nodal response to neoadjuvant treatment in breast cancer with core biopsy biomarkers of tumor microenvironment using data mining
Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?
“Major pathologic response” in lymph nodes: a modified nodal classification for non-small cell lung cancer patients treated with neoadjuvant immunochemotherapy
Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence
Nodal user’s demand response based on incentive based programs
Prediction of pathological response to neo‐adjuvant chemoradiotherapy for oesophageal cancer using vibrational spectroscopy
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT
Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
Predicting nodal response to neoadjuvant treatment in breast cancer with core biopsy biomarkers of tumor microenvironment using data mining
Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?
“Major pathologic response” in lymph nodes: a modified nodal classification for non-small cell lung cancer patients treated with neoadjuvant immunochemotherapy
Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence
Nodal user’s demand response based on incentive based programs
Prediction of pathological response to neo‐adjuvant chemoradiotherapy for oesophageal cancer using vibrational spectroscopy
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT
Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
Predicting nodal response to neoadjuvant treatment in breast cancer with core biopsy biomarkers of tumor microenvironment using data mining
Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?
“Major pathologic response” in lymph nodes: a modified nodal classification for non-small cell lung cancer patients treated with neoadjuvant immunochemotherapy
Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence